Home LiteratureArticle Details
PMID: 18728234 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Ablation of AMP-activated protein kinase alpha2 activity exacerbates insulin resistance induced by high-fat feeding of mice.

Diabetes ·Vol. 57 ·No. 11 ·2008-11-00 ·Pages 2958-66

Fujii N, Ho RC, Manabe Y, Jessen N, Toyoda T, Holland WL, Summers SA, Hirshman MF, Goodyear LJ

Abstract

We determined whether muscle AMP-activated protein kinase (AMPK) has a role in the development of insulin resistance. Muscle-specific transgenic mice expressing an inactive form of the AMPK alpha2 catalytic subunit (alpha2i TG) and their wild-type littermates were fed either a high-fat (60% kcal fat) or a control (10% kcal fat) diet for 30 weeks. Compared with wild-type mice, glucose tolerance in alpha2i TG mice was slightly impaired on the control diet and significantly impaired on the high-fat diet. To determine whether the whole-body glucose intolerance was associated with impaired insulin sensitivity in skeletal muscle, glucose transport in response to submaximal insulin (450 microU/ml) was measured in isolated soleus muscles. On the control diet, insulin-stimulated glucose transport was reduced by approximately 50% in alpha2i TG mice compared with wild-type mice. High-fat feeding partially decreased insulin-stimulated glucose transport in wild-type mice, while high-fat feeding resulted in a full blunting of insulin-stimulated glucose transport in the alpha2i TG mice. High-fat feeding in alpha2i TG mice was accompanied by decreased expression of insulin signaling proteins in gastrocnemius muscle. The lack of skeletal muscle AMPK alpha2 activity exacerbates the development of glucose intolerance and insulin resistance caused by high-fat feeding and supports the thesis that AMPK alpha2 is an important target for the prevention/amelioration of skeletal muscle insulin resistance through lifestyle (exercise) and pharmacologic (e.g., metformin) treatments.

MeSH Terms
AMP-Activated Protein Kinases/genetics,metabolism Animals Blood Glucose/metabolism Body Weight/drug effects Dietary Fats/administration & dosage Fatty Acids, Nonesterified/blood Glucose/metabolism Glucose Tolerance Test Glycogen/metabolism Immunoblotting Insulin/blood Insulin Resistance Mice Mice, Transgenic Muscles/drug effects,metabolism Triglycerides/blood
Chemicals
Blood Glucose Dietary Fats Fatty Acids, Nonesterified Insulin Triglycerides Glycogen AMP-Activated Protein Kinases Glucose
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Fujii Nobuharu
Department of Medicine, Research Division, Joslin Diabetes Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Ho Richard C
Manabe Yasuko
Jessen Niels
Toyoda Taro
Holland William L
Summers Scott A
Hirshman Michael F
Goodyear Laurie J
References (53)
53 references, click to expand
  1. Fuel selection in human skeletal muscle in insulin resistance: a reexamination.
    Diabetes. 2000 May;49(5):677-83 PMID: 10905472
  2. Diet-induced changes in stearoyl-CoA desaturase 1 expression in obesity-prone and -resistant mice.
    Obes Res. 2004 Aug;12(8):1264-70 PMID: 15340109
  3. AMP-activated protein kinase signaling in metabolic regulation.
    J Clin Invest. 2006 Jul;116(7):1776-83 PMID: 16823475
  4. Isoform-specific regulation of 5' AMP-activated protein kinase in skeletal muscle from obese Zucker (fa/fa) rats in response to contraction.
    Diabetes. 2002 Sep;51(9):2703-8 PMID: 12196462
  5. Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.
    Diabetes. 2001 May;50(5):1076-82 PMID: 11334411
  6. 5'-AMP-activated protein kinase activity and protein expression are regulated by endurance training in human skeletal muscle.
    Am J Physiol Endocrinol Metab. 2004 Mar;286(3):E411-7 PMID: 14613924
  7. Dealing with energy demand: the AMP-activated protein kinase.
    Trends Biochem Sci. 1999 Jan;24(1):22-5 PMID: 10087918
  8. Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles.
    J Appl Physiol (1985). 2003 Apr;94(4):1373-9 PMID: 12496137
  9. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle.
    Mol Cell. 2001 May;7(5):1085-94 PMID: 11389854
  10. Increased expression of GLUT-4 and hexokinase in rat epitrochlearis muscles exposed to AICAR in vitro.
    J Appl Physiol (1985). 2000 Mar;88(3):1072-5 PMID: 10710405
  11. The regulation of AMP-activated protein kinase by phosphorylation.
    Biochem J. 2000 Feb 1;345 Pt 3:437-43 PMID: 10642499
  12. 5-amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes.
    Diabetes. 2003 May;52(5):1066-72 PMID: 12716734
  13. The AMP-activated protein kinase cascade--a unifying system for energy control.
    Trends Biochem Sci. 2004 Jan;29(1):18-24 PMID: 14729328
  14. AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise.
    Diabetes. 2001 May;50(5):921-7 PMID: 11334434
  15. Overexpression or ablation of JNK in skeletal muscle has no effect on glycogen synthase activity.
    Am J Physiol Cell Physiol. 2004 Jul;287(1):C200-8 PMID: 15013949
  16. Rosiglitazone treatment enhances acute AMP-activated protein kinase-mediated muscle and adipose tissue glucose uptake in high-fat-fed rats.
    Diabetes. 2006 Oct;55(10):2797-804 PMID: 17003345
  17. AMP-activated protein kinase activation by AICAR increases both muscle fatty acid and glucose uptake in white muscle of insulin-resistant rats in vivo.
    Diabetes. 2004 Jul;53(7):1649-54 PMID: 15220186
  18. Long-term AICAR administration and exercise prevents diabetes in ZDF rats.
    Diabetes. 2005 Apr;54(4):928-34 PMID: 15793229
  19. The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.
    J Biol Chem. 2002 Jul 12;277(28):25226-32 PMID: 11994296
  20. AMP-activated protein kinase alpha2 activity is not essential for contraction- and hyperosmolarity-induced glucose transport in skeletal muscle.
    J Biol Chem. 2005 Nov 25;280(47):39033-41 PMID: 16186119
  21. LKB1-AMPK signaling in muscle from obese insulin-resistant Zucker rats and effects of training.
    Am J Physiol Endocrinol Metab. 2006 May;290(5):E925-32 PMID: 16352671
  22. Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes, and hyperlipidemia.
    Endocrinology. 1996 Jan;137(1):21-9 PMID: 8536614
  23. A role for the microtubular system in the release of very low density lipoproteins by perfused mouse livers.
    J Biol Chem. 1973 Oct 10;248(19):6862-70 PMID: 4355507
  24. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.
    Ann Intern Med. 1990 Dec 15;113(12):909-15 PMID: 2240915
  25. Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia.
    Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E172-81 PMID: 17374701
  26. Prior serum- and AICAR-induced AMPK activation in primary human myocytes does not lead to subsequent increase in insulin-stimulated glucose uptake.
    Am J Physiol Endocrinol Metab. 2004 Sep;287(3):E553-7 PMID: 15149951
  27. Contraction-stimulated muscle glucose transport and GLUT-4 surface content are dependent on glycogen content.
    Am J Physiol. 1999 Dec;277(6):E1103-10 PMID: 10600801
  28. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes.
    Am J Physiol. 1999 Jul;277(1):E1-10 PMID: 10409121
  29. Quantitative determination of ceramide using diglyceride kinase.
    Methods Enzymol. 2000;312:22-31 PMID: 11070860
  30. The role of intramuscular lipid in insulin resistance.
    Acta Physiol Scand. 2003 Aug;178(4):373-83 PMID: 12864742
  31. 5-aminoimidazole-4-carboxy-amide-1-beta-D-ribofuranoside treatment ameliorates hyperglycaemia and hyperinsulinaemia but not dyslipidaemia in KKAy-CETP mice.
    Diabetologia. 2001 Dec;44(12):2180-6 PMID: 11793019
  32. AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats.
    Diabetes. 2002 Oct;51(10):2886-94 PMID: 12351423
  33. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding.
    Biochem J. 2000 Mar 15;346 Pt 3:659-69 PMID: 10698692
  34. AMP-activated protein kinase and the regulation of glucose transport.
    Am J Physiol Endocrinol Metab. 2006 Nov;291(5):E867-77 PMID: 16822958
  35. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade.
    Diabetes. 1999 Jun;48(6):1270-4 PMID: 10342815
  36. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell?
    Annu Rev Biochem. 1998;67:821-55 PMID: 9759505
  37. Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle.
    J Appl Physiol (1985). 2001 Sep;91(3):1017-28 PMID: 11509493
  38. AICAR and hyperosmotic stress increase insulin-stimulated glucose transport.
    J Appl Physiol (1985). 2005 Sep;99(3):877-83 PMID: 15860681
  39. Decreased insulin-stimulated GLUT-4 translocation in glycogen-supercompensated muscles of exercised rats.
    Am J Physiol. 1999 May;276(5):E907-12 PMID: 10329985
  40. 5-Aminoimidazole-4-carboxamide 1-beta -D-ribofuranoside (AICAR) stimulates myocardial glycogenolysis by allosteric mechanisms.
    Am J Physiol Regul Integr Comp Physiol. 2003 Apr;284(4):R936-44 PMID: 12626360
  41. Chronic activation of 5'-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle.
    J Appl Physiol (1985). 1999 Nov;87(5):1990-5 PMID: 10562646
  42. Role of glycogen concentration and epinephrine on glucose uptake in rat epitrochlearis muscle.
    Am J Physiol. 1997 Apr;272(4 Pt 1):E649-55 PMID: 9142887
  43. Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis.
    Cell Metab. 2007 Feb;5(2):151-6 PMID: 17276357
  44. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes.
    Diabetes. 2002 Jul;51(7):2074-81 PMID: 12086935
  45. Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin.
    Am J Physiol Endocrinol Metab. 2002 Jan;282(1):E18-23 PMID: 11739078
  46. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle.
    J Biol Chem. 2002 Dec 27;277(52):50230-6 PMID: 12006582
  47. Malonyl-CoA, fuel sensing, and insulin resistance.
    Am J Physiol. 1999 Jan;276(1):E1-E18 PMID: 9886945
  48. AMPK activity and isoform protein expression are similar in muscle of obese subjects with and without type 2 diabetes.
    Am J Physiol Endocrinol Metab. 2004 Feb;286(2):E239-44 PMID: 14532170
  49. Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling.
    Cell Metab. 2006 Dec;4(6):465-74 PMID: 17141630
  50. Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes.
    Diabetes. 1991 Oct;40(10):1259-66 PMID: 1657665
  51. Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle.
    J Biol Chem. 2004 Jan 9;279(2):1070-9 PMID: 14573616
  52. Glucose, exercise and insulin: emerging concepts.
    J Physiol. 2001 Sep 1;535(Pt 2):313-22 PMID: 11533125
  53. 5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice.
    Diabetologia. 2002 Jan;45(1):56-65 PMID: 11845224
Article Info
Journal
Diabetes
Abbr.
Diabetes
ISSN
1939-327X
Published
2008-11-00
Epub
2008-00-26
Pages
2958-66
Language
English
Region
United States
NLM ID
0372763
PMCID
PMC2570392
Subset
IM
Grants
NIAMS NIH HHS · R01 AR45670 · United States
NIAMS NIH HHS · F32 AR049662 · United States
NIDDK NIH HHS · P30 DK036836 · United States
NIDDK NIH HHS · R01 DK068626 · United States
NIAMS NIH HHS · R01 AR045670 · United States
NIDDK NIH HHS · DK36836 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com